Analysis of the genomes of patients with schizophrenia has shown numerous copy number variations that increase the risk of developing the neurodegenerative disease. Significantly, many of these variations occur in genes that affect signaling among brain cells.
"When we compared the genomes of patients with schizophrenia to those of healthy subjects, we found variations in genes that regulate brain functions, several of which are already known to be perturbed in patients with this disorder. Although much research remains to be done, detecting genes on specific pathways is a first step to identifying more specific targets for improved drug treatments," said study leader Dr. Hakon Hakonarson, director of the Center for Applied Genomics at The Children's Hospital of Philadelphia.
A devastating psychiatric disorder that affects an estimated 1.5 percent of the population, schizophrenia may include hallucinations, disorganized speech, abnormal thought processes and other symptoms.
The researchers compared DNA samples from a total of 1,735 adult patients with schizophrenia to DNA from 3,485 healthy adult subjects, using highly automated genotyping tools.
They used a whole-genome approach, covering the full set of genetic material from each individual, following their first analysis with a replication study.
The study team found copy number variations (CNVs) in or near genes that play important roles in the brain.
Advertisement
Two other genes, RET and RIT2, are members of another signalling gene family known to be involved in brain development.
Advertisement
"Although different brain regions may be affected in these different neuropsychiatric disorders, these overlaps suggest that there may be common features in their underlying pathogenesis. These genes affect synaptic function, so deletions or duplications in those genes may alter how brain circuits are formed," said Hakonarson.
The research appears in the Proceedings of the National Academy of Sciences.
Source-ANI
RAS